Application of real-time global media monitoring and ‘derived questions’ for enhancing communication by regulatory bodies: the case of human papillomavirus vaccines-Reference-Cited by-同舟云学术

Application of real-time global media monitoring and ‘derived questions’ for enhancing communication by regulatory bodies: the case of human papillomavirus vaccines

Published:2017-05-02 Issue:1 Volume:15 Page:
ISSN:1741-7015
Container-title:BMC Medicine
language:en
Short-container-title:BMC Med

Author:

Bahri Priya, ,Fogd Julianna,Morales Daniel,Kurz Xavier

Funder

Innovative Medicines Initiative (IMI) Joint Undertaking

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12916-017-0850-4.pdf

Reference70 articles.

1. Leach M, Fairhead J. Vaccine anxieties: global science, child health and society. London: Taylor & Francis Earthscan; 2007.

2. World Health Organization (WHO) SAGE working group dealing with vaccine hesitancy. Strategies for addressing vaccine hesitancy: a systematic review. Geneva: WHO; 2014. http://www.who.int/immunization/sage/meetings/2014/october/3_SAGE_WG_Strategies_addressing_vaccine_hesitancy_2014.pdf .

3. European Medicines Agency (EMA) and Heads of Medicines Agencies. Guideline on good pharmacovigilance practices — product- or population-specific considerations I: vaccines for prophylaxis against infectious diseases. London: EMA; 2013. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000345.jsp&mid=WC0b01ac058058f32c .

4. Bahri P. Public pharmacovigilance communication: a process calling for evidence-based, objective-driven strategies. Drug Saf. 2010;33:1065–79.

5. Larson H, Brocard Paterson P, Erondu N. The globalization of risk and risk perception: why we need a new model of risk communication for vaccines. Drug Saf. 2012;35:1053–9.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The STAR Compass to Guide Future Pharmacovigilance Based on a 10-Year Review of the Strengthened EU System;Drug Safety;2024-07-10

2. Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance;Drug Safety;2023-05-23

3. Digital tools, multidisciplinarity and innovation for communicating vaccine safety in the COVID-19 era;Human Vaccines & Immunotherapeutics;2021-03-25

4. Methods for Social Media Monitoring Related to Vaccination: Systematic Scoping Review;JMIR Public Health and Surveillance;2021-02-08

5. Why we need more collaboration in Europe to enhance post-marketing surveillance of vaccines;Vaccine;2020-12